Russia’s focus on domestic pharma production could shield it from sanctions’ effects
Russia’s pharma manufacturing is more focused on the domestic market due to its comparative lack of FDA and EMA approvals.
By
Drug Manufacturers
Latest in
Drug Manufacturers
Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years
In the first edition of Pharmaceutical Technology’s series on the FDA’s orphan drug program, we examine how its popularity has…
By
Non-stop investment from CMOs and US Government into continuous manufacturing
CMOs have been increasingly adopting the use of continuous manufacturing for biologics production following FDA approval.
By
Alto Neuroscience uses AI to create biomarkers for personalised mental health drugs
GlobalData’s Drugs Database reveals that more than 490 unique drugs have been discovered using AI-based technologies.
By
Pfizer plans $120m investment for Covid-19 oral drug manufacturing in US
The latest expansion will create more than 250 new high-skilled manufacturing jobs at the company’s Kalamazoo facility.
CMO Moves: Regulatory catalysts for drug manufacturing-March
Pharmaceutical Technology does a roundup of regulatory decisions in recent months that impact drugs and the CMOs enlisted to manufacture…
By
Hyundai to submit fast track processing request to FDA for monkeypox drug
The move comes after the company learned that CP-COV03 could receive a fast-track processing under the Animal Rule.
Lilly to expand manufacturing capability in US with $2.1bn investment
The project is anticipated to generate up to 500 new job roles in the company.